Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Therapeutics Market (2023-2028) by Therapeutic Type, Drug Type, Application, End-User and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Cancer Therapeutics Market is predicted to reach USD 160.05 billion by 2028, growing at a CAGR of 8.52% from an estimated USD 106.34 billion in 2023. This sector involves developing and implementing treatments like chemotherapy, radiation therapy, immunotherapy, targeted medicines, and precision medicine to combat cancer while minimizing harm to healthy cells.
Market Growth Drivers:
Governments globally are heavily investing in cancer treatment research and development, fostering new medicine creation, improved clinical trials, and faster translation of scientific advances into effective therapies. With a rising global cancer prevalence, there's an increased focus on research, leading to insights, therapeutic targets, and new treatments.
Advanced understanding of cancer's molecular basis drives demand for personalized treatment through targeted medicines, enhancing patient outcomes and fueling the market. Rapid technological progress in genomics, proteomics, and bioinformatics transforms cancer research, enabling better treatment discovery. Favorable government policies, tax breaks, and research funding boost investment and market expansion.
Collaborations among pharmaceutical companies, research institutions, and healthcare practitioners facilitate multidisciplinary approaches, resource sharing, and cooperative development, fostering new therapeutic solutions and market growth.
Market Challenges:
High treatment costs, especially for advanced therapies, strain patients and healthcare systems. Despite advances, treatment failures and side effects remain challenges. Minimizing these side effects is crucial for patient safety and quality care.
Market Segmentations:
Segments include Therapeutic Type, Application, Drug Type, End-User, and Geography. The Cancer Chemotherapy segment holds significant market share due to its applicability across various cancer types.
Recent Developments
- Astellas Completes Acquisition of Iveric Bio - July 2023
- Johnson & Johnson Completes Acquisition of Abiomed. Broadens MedTech Portfolio with World Leading Solutions for Heart Recovery - December 2022
Why buy this report?
- The report offers a comprehensive evaluation of the Global Cancer Therapeutics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
- Excel data sheet for the market size will also be provided with the report.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
- The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors
- The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.
Companies Mentioned
- AbbVie Inc.
- Amgen Inc
- Astellas Pharma Inc
- AstraZeneca PLC
- Bayer AG
- BeiGene, Ltd.
- Bristol Myers Squibb Company
- Celgene Corp
- Eisai Co., Ltd.
- EnGeneIC Ltd
- Exelixis, Inc.
- F. Hoffmann-La Roche Ltd
- Genentech
- Johnson and Johnson
- Lilly
- Merck and co
- Novartis
- Pfizer Inc.
- Roche Holding AG
- Sanofi
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 188 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $106.34 Billion |
| Forecasted Market Value (USD) by 2028 | $160.05 Billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/3iddjg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
